BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garriga M, Mallorquí A, Serrano L, Ríos J, Salamero M, Parellada E, Gómez-ramiro M, Oliveira C, Amoretti S, Vieta E, Bernardo M, García-rizo C. Food craving and consumption evolution in patients starting treatment with clozapine. Psychopharmacology 2019;236:3317-27. [DOI: 10.1007/s00213-019-05291-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Sankaranarayanan A, Johnson K, Mammen SJ, Wilding HE, Vasani D, Murali V, Mitchison D, Castle DJ, Hay P. Disordered Eating among People with Schizophrenia Spectrum Disorders: A Systematic Review. Nutrients 2021;13:3820. [PMID: 34836076 DOI: 10.3390/nu13113820] [Reference Citation Analysis]
2 Stogios N, Smith E, Asgariroozbehani R, Hamel L, Gdanski A, Selby P, Sockalingam S, Graff-Guerrero A, Taylor VH, Agarwal SM, Hahn MK. Exploring Patterns of Disturbed Eating in Psychosis: A Scoping Review. Nutrients 2020;12:E3883. [PMID: 33353080 DOI: 10.3390/nu12123883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 George MY, Menze ET, Esmat A, Tadros MG, El-Demerdash E. Naringin treatment improved main clozapine-induced adverse effects in rats; emphasis on weight gain, metabolic abnormalities, and agranulocytosis. Drug Dev Res 2021. [PMID: 33537987 DOI: 10.1002/ddr.21800] [Reference Citation Analysis]
4 Garriga M, Mallorquí A, Bernad S, Ruiz-Cortes V, Oliveira C, Amoretti S, Mezquida G, Bioque M, Molina O, Gómez-Ramiro M, Vieta E, Bernardo M, Parellada E, García-Rizo C. Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine Treatment. J Clin Psychopharmacol 2022;42:75-80. [PMID: 34928563 DOI: 10.1097/JCP.0000000000001483] [Reference Citation Analysis]
5 Simon MS, Barton B, Zagler A, Engl K, Rihs L, Glocker C, Musil R. Lifestyle behaviors, metabolic disturbances, and weight gain in psychiatric inpatients treated with weight gain-associated medication. Eur Arch Psychiatry Clin Neurosci 2022. [PMID: 35778522 DOI: 10.1007/s00406-022-01442-4] [Reference Citation Analysis]